Related references
Note: Only part of the references are listed.Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Lewis B. Silverman et al.
BLOOD (2010)
Peg-asparaginase for acute lymphoblastic leukemia
Michael Rytting
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia
Elizabeth A. Raetz et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Pegasparaginase: where do we stand?
Amer Zeidan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia
Umesh K. Narta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:: a Children's Cancer Group study
VI Avramis et al.
BLOOD (2002)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
LB Silverman et al.
BLOOD (2001)
Share Paper
